Spencer Pharmaceutical (SPPH)

[scion]

VI. IT IS HEREBY FURTHER ORDERED, ADJUDGED, AND DECREED that:

(a) Amyot, Hilbroy, and IAB Media are jointly and severally liable for disgorgement of $3,055,890.80, representing profits gained as a result of the misconduct alleged in the Complaint, together with prejudgment interest thereon in the amount of $371,130.20, for a total amount of $3,427,021.00;

(b) Amyot is solely liable for additional disgorgement of $2,186,743.87, representing profits gained as a result of the misconduct alleged in the Complaint, together with prejudgment interest thereon in the amount of $265,574.51, for a total amount of $2,452,318.38;

(c) Amyot is liable for a civil penalty in the amount of $_____________ pursuant to Section 20(d)(2) of the Securities Act [15 U.S.C. §77t(d)(2)] and Section 21(d)(3) of the Exchange Act [15 U.S.C. §78u(d)(3)];

Extract -
Doc 181-1 PDF file
https://www.scribd.com/doc/249698921/SEC-v-Spencer-Pharmaceutical-Inc-Et-Al-Doc-181-1-Filed-08-Dec-14